CIBC Raises Kinaxis (TSE:KXS) Price Target to C$201.00

Kinaxis (TSE:KXSGet Free Report) had its target price boosted by CIBC from C$198.00 to C$201.00 in a report released on Wednesday,BayStreet.CA reports. The firm presently has a “neutral” rating on the stock. CIBC’s price target would suggest a potential upside of 19.17% from the company’s current price.

Other equities analysts also recently issued research reports about the company. Scotiabank increased their price objective on Kinaxis from C$225.00 to C$240.00 and gave the stock an “outperform” rating in a report on Friday, August 8th. TD Securities lifted their target price on shares of Kinaxis from C$190.00 to C$225.00 and gave the stock a “buy” rating in a report on Friday, October 3rd. National Bankshares set a C$240.00 price target on Kinaxis and gave the company an “outperform” rating in a report on Thursday, October 23rd. Royal Bank Of Canada upped their price target on Kinaxis from C$225.00 to C$235.00 in a report on Friday, August 8th. Finally, Stifel Nicolaus increased their target price on Kinaxis from C$225.00 to C$245.00 and gave the company a “buy” rating in a report on Thursday, July 31st. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Kinaxis has an average rating of “Moderate Buy” and a consensus target price of C$227.63.

Check Out Our Latest Stock Report on Kinaxis

Kinaxis Price Performance

Shares of KXS stock opened at C$168.66 on Wednesday. The business’s 50 day moving average price is C$183.37 and its 200-day moving average price is C$191.48. The firm has a market cap of C$4.77 billion, a P/E ratio of 196.12, a P/E/G ratio of 3.60 and a beta of 0.77. The company has a debt-to-equity ratio of 12.12, a quick ratio of 2.29 and a current ratio of 1.89. Kinaxis has a fifty-two week low of C$149.96 and a fifty-two week high of C$212.45.

Insider Buying and Selling at Kinaxis

In other news, insider Mark Justin Morgan sold 2,281 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of C$198.63, for a total value of C$453,081.87. Following the completion of the sale, the insider directly owned 11,000 shares of the company’s stock, valued at C$2,184,963. This trade represents a 17.17% decrease in their position. Also, insider Andrew William Robert Bell sold 275 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of C$193.18, for a total value of C$53,124.50. Following the completion of the sale, the insider directly owned 1,919 shares of the company’s stock, valued at C$370,712.42. The trade was a 12.53% decrease in their ownership of the stock. Insiders sold 8,656 shares of company stock worth $1,665,206 in the last quarter. 1.20% of the stock is owned by corporate insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm’s flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.